Natural compound Alternol exerts a broad anti-cancer spectrum and a superior therapeutic safety index
Alternol
anti-cancer drug
natural compound
ovarian cancer
prostate cancer
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2024
2024
Historique:
received:
30
03
2024
accepted:
06
05
2024
medline:
10
6
2024
pubmed:
10
6
2024
entrez:
10
6
2024
Statut:
epublish
Résumé
Alternol is a natural compound isolated from the fermentation of a mutated fungus. We have demonstrated its potent anti-cancer effect We first tested its anti-cancer spectrum using the National Cancer Institute-60 (NCI-60) screening, a protein quantitation-based assay. CellTiter-Glo screening was utilized for ovarian cancer cell lines. Cell cycle distribution was analyzed using flow cytometry. Xenograft models in nude mice were used to assess anti-cancer effect. Healthy mice were tested for the acuate systemic toxicity. Our results showed that Alternol exerted a potent anti-cancer effect on 50 (83%) cancer cell lines with a GI Taken together, Alternol has a broad anti-cancer spectrum with a safe therapeutic index
Identifiants
pubmed: 38855749
doi: 10.3389/fphar.2024.1409506
pii: 1409506
pmc: PMC11157072
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1409506Informations de copyright
Copyright © 2024 He, Ma, Hirst, Li, Wu, Liu, Zhao, Xu, Godwin, Wang and Li.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.